Aural Analytics, Inc. Announces the Launch of A2E, A Software Development Kit for Clinical-Grade Speech Collection and Analytics
Summary
Aural Analytics’ A2E system is built to solve these industry challenges by enabling speech collection and analytics via embeddable short, simple speech tasks that lower patient burden and maximize clinical insight - all while seamlessly fitting into existing software and hardware offerings. A2E supports simple technical integration and includes a service division dedicated to setup, implementation and administration. This system is incredibly easy to implement, works across languages, devices and use-cases, and is safe and secure - all while bringing about a seamless user experience that our integration partners can be proud of.” The A2E technology is based on nearly 30 years of speech neuroscience research, and includes a mobile application SDK with cloud-based computation that powers disease-specific speech tasks and analytics for use in clinical trials, telemedicine, remote monitoring and consumer applications. Currently available in 14 languages, Aural Analytics’ technologies provide rich, interpretable and validated metrics reflecting the neurological and respiratory health of its users. The company is founded on nearly three decades of NIH and NSF-funded research in speech neuroscience, is backed by dozens of high-caliber scientific publications, and has won several awards for its work in the field, including the prestigious Global SCRIP Award for Best Technology Development in Clinical Trials.